APA Citatie

Askoxylakis, V., Ferraro, G. B., Badeaux, M., Kodack, D. P., Kirst, I., Shankaraiah, R. C., . . . Jain, R. K. (2019). Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer. NPJ Breast Cancer.

Chicago Style citaat

Askoxylakis, Vasileios, et al. "Dual Endothelin Receptor Inhibition Enhances T-DM1 Efficacy in Brain Metastases From HER2-positive Breast Cancer." NPJ Breast Cancer 2019.

MLA citatie

Askoxylakis, Vasileios, et al. "Dual Endothelin Receptor Inhibition Enhances T-DM1 Efficacy in Brain Metastases From HER2-positive Breast Cancer." NPJ Breast Cancer 2019.